# Michael Böhm

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michael-bohm/

## Facts

| Field | Value |
| --- | --- |
| Citations | 179,434 |
| Field | Heart Failure Treatment and Management |
| h-index | 165 |
| i10-index | 1,026 |
| Last Known Institution | Klinik Hietzing |
| OpenAlex ID | https://openalex.org/A5008678419 |
| ORCID iD | 0000-0002-2976-2514 |
| Works | 1,836 |

## Researcher papers

Showing 12 of 44.

- [2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure](https://scholariq.org/papers/2021-esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart/)
- [Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction](https://scholariq.org/papers/dapagliflozin-in-patients-with-heart-failure-and-reduced-ejection-fraction/)
- [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC](https://scholariq.org/papers/esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart-2/)
- [Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure](https://scholariq.org/papers/cardiovascular-and-renal-outcomes-with-empagliflozin-in-heart-failure/)
- [Empagliflozin in Heart Failure with a Preserved Ejection Fraction](https://scholariq.org/papers/empagliflozin-in-heart-failure-with-a-preserved-ejection-fraction/)
- [ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008](https://scholariq.org/papers/esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart-3/)
- [Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock](https://scholariq.org/papers/intraaortic-balloon-support-for-myocardial-infarction-with-cardiogenic-shock/)
- [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)](https://scholariq.org/papers/esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart/)
- [Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy](https://scholariq.org/papers/clinical-features-and-outcomes-of-takotsubo-stress-cardiomyopathy/)
- [Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study](https://scholariq.org/papers/ivabradine-and-outcomes-in-chronic-heart-failure-shift-a-randomised-placebo/)
- [2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure](https://scholariq.org/papers/2023-focused-update-of-the-2021-esc-guidelines-for-the-diagnosis-and-treatment/)
- [2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure](https://scholariq.org/papers/2021-esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart-2/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Heart Rate Variability and Autonomic Control](https://scholariq.org/topics/heart-rate-variability-and-autonomic-control/)
- [Heart rate and cardiovascular health](https://scholariq.org/topics/heart-rate-and-cardiovascular-health/)

## Researcher university

- [Klinik Hietzing](https://scholariq.org/institutions/klinik-hietzing/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.